Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE)

Nicolas W. Shammas, Gail A. Shammas, Sue Jones-Miller, W. John Shammas, Bassel Bou-Dargham, Andrew N. Shammas, Subhash Banerjee, Rayan Jo Rachwan, Ghassan E. Daher

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: The long-term outcome of Jetstream atherectomy (JA) with or without adjunctive drug coated balloons (DCB) in a real-world setting remains unknown. We report 16-month target lesion revascularization (TLR) rates on patients treated for femoropopliteal (FP) artery disease with JA in a single center by one operator. Methods: From 1/1/12 to 8/24/16 a total of 311 procedures were performed with atherectomy by a single operator at a single center. Of these procedures, 75 met inclusion and exclusion criteria. This report evaluates the outcomes of these 75 patients treated at index and who were followed up to 16 months. The primary endpoint of the study was clinically driven TLR. Patients were stratified by the use of DCB (vs angioplasty (PTA)) post-JA. TLR was calculated by excluding bailout stenting as TLR. Survival analysis for TLR over time was plotted. Results: 75 patients (49.3% male, mean age 68.0 years, 54.7% diabetes) with de novo or restenotic FP lesions whose symptoms were classified as Rutherford category I-V were enrolled. Adjunctive PTA was performed on 50 patients (26 de novo, 13 in-stent restenosis, 3 non-stent restenosis, 8 mixed lesions) and adjunctive DCB (LUTONIX® 24, IN.PACT® 1) on 25 patients (21 de novo, 1 in-stent restenosis, 2 non-stent restenosis, 1 mixed lesion) (p = 0.0249). There was no difference in the median treated length between the adjunctive PTA (15 cm) and DCB (10 cm) groups (p = 0.0530). The estimated freedom from TLR (fTLR) was significantly higher with atherectomy and adjunctive DCB compared to atherectomy with adjunctive PTA at 12 months (94.7% vs 68.0%, p = 0.002) and 16 months (94.4% vs 54%; p = 0.002). Conclusions: In a single center cohort of JA reflecting real-world practice, JA with DCB had a superior TLR rate up to 16-month follow-up when compared to JA with PTA in treating all comers FP arterial disease.

Original languageEnglish (US)
JournalCardiovascular Revascularization Medicine
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Atherectomy
Arteries
Pharmaceutical Preparations
Stents
Balloon Angioplasty
Survival Analysis

Keywords

  • Atherectomy
  • De novo lesions
  • Drug coated balloon
  • Jetstream
  • Outcome
  • Popliteal artery
  • Restenotic lesions
  • Superficial femoral artery

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries : A single center experience (JET-SCE). / Shammas, Nicolas W.; Shammas, Gail A.; Jones-Miller, Sue; Shammas, W. John; Bou-Dargham, Bassel; Shammas, Andrew N.; Banerjee, Subhash; Rachwan, Rayan Jo; Daher, Ghassan E.

In: Cardiovascular Revascularization Medicine, 01.01.2018.

Research output: Contribution to journalArticle

Shammas, Nicolas W. ; Shammas, Gail A. ; Jones-Miller, Sue ; Shammas, W. John ; Bou-Dargham, Bassel ; Shammas, Andrew N. ; Banerjee, Subhash ; Rachwan, Rayan Jo ; Daher, Ghassan E. / Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries : A single center experience (JET-SCE). In: Cardiovascular Revascularization Medicine. 2018.
@article{b1e8ae7803e0431cb3befecae1e28c4a,
title = "Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE)",
abstract = "Background: The long-term outcome of Jetstream atherectomy (JA) with or without adjunctive drug coated balloons (DCB) in a real-world setting remains unknown. We report 16-month target lesion revascularization (TLR) rates on patients treated for femoropopliteal (FP) artery disease with JA in a single center by one operator. Methods: From 1/1/12 to 8/24/16 a total of 311 procedures were performed with atherectomy by a single operator at a single center. Of these procedures, 75 met inclusion and exclusion criteria. This report evaluates the outcomes of these 75 patients treated at index and who were followed up to 16 months. The primary endpoint of the study was clinically driven TLR. Patients were stratified by the use of DCB (vs angioplasty (PTA)) post-JA. TLR was calculated by excluding bailout stenting as TLR. Survival analysis for TLR over time was plotted. Results: 75 patients (49.3{\%} male, mean age 68.0 years, 54.7{\%} diabetes) with de novo or restenotic FP lesions whose symptoms were classified as Rutherford category I-V were enrolled. Adjunctive PTA was performed on 50 patients (26 de novo, 13 in-stent restenosis, 3 non-stent restenosis, 8 mixed lesions) and adjunctive DCB (LUTONIX{\circledR} 24, IN.PACT{\circledR} 1) on 25 patients (21 de novo, 1 in-stent restenosis, 2 non-stent restenosis, 1 mixed lesion) (p = 0.0249). There was no difference in the median treated length between the adjunctive PTA (15 cm) and DCB (10 cm) groups (p = 0.0530). The estimated freedom from TLR (fTLR) was significantly higher with atherectomy and adjunctive DCB compared to atherectomy with adjunctive PTA at 12 months (94.7{\%} vs 68.0{\%}, p = 0.002) and 16 months (94.4{\%} vs 54{\%}; p = 0.002). Conclusions: In a single center cohort of JA reflecting real-world practice, JA with DCB had a superior TLR rate up to 16-month follow-up when compared to JA with PTA in treating all comers FP arterial disease.",
keywords = "Atherectomy, De novo lesions, Drug coated balloon, Jetstream, Outcome, Popliteal artery, Restenotic lesions, Superficial femoral artery",
author = "Shammas, {Nicolas W.} and Shammas, {Gail A.} and Sue Jones-Miller and Shammas, {W. John} and Bassel Bou-Dargham and Shammas, {Andrew N.} and Subhash Banerjee and Rachwan, {Rayan Jo} and Daher, {Ghassan E.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.carrev.2018.02.003",
language = "English (US)",
journal = "Cardiovascular Revascularization Medicine",
issn = "1553-8389",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries

T2 - A single center experience (JET-SCE)

AU - Shammas, Nicolas W.

AU - Shammas, Gail A.

AU - Jones-Miller, Sue

AU - Shammas, W. John

AU - Bou-Dargham, Bassel

AU - Shammas, Andrew N.

AU - Banerjee, Subhash

AU - Rachwan, Rayan Jo

AU - Daher, Ghassan E.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: The long-term outcome of Jetstream atherectomy (JA) with or without adjunctive drug coated balloons (DCB) in a real-world setting remains unknown. We report 16-month target lesion revascularization (TLR) rates on patients treated for femoropopliteal (FP) artery disease with JA in a single center by one operator. Methods: From 1/1/12 to 8/24/16 a total of 311 procedures were performed with atherectomy by a single operator at a single center. Of these procedures, 75 met inclusion and exclusion criteria. This report evaluates the outcomes of these 75 patients treated at index and who were followed up to 16 months. The primary endpoint of the study was clinically driven TLR. Patients were stratified by the use of DCB (vs angioplasty (PTA)) post-JA. TLR was calculated by excluding bailout stenting as TLR. Survival analysis for TLR over time was plotted. Results: 75 patients (49.3% male, mean age 68.0 years, 54.7% diabetes) with de novo or restenotic FP lesions whose symptoms were classified as Rutherford category I-V were enrolled. Adjunctive PTA was performed on 50 patients (26 de novo, 13 in-stent restenosis, 3 non-stent restenosis, 8 mixed lesions) and adjunctive DCB (LUTONIX® 24, IN.PACT® 1) on 25 patients (21 de novo, 1 in-stent restenosis, 2 non-stent restenosis, 1 mixed lesion) (p = 0.0249). There was no difference in the median treated length between the adjunctive PTA (15 cm) and DCB (10 cm) groups (p = 0.0530). The estimated freedom from TLR (fTLR) was significantly higher with atherectomy and adjunctive DCB compared to atherectomy with adjunctive PTA at 12 months (94.7% vs 68.0%, p = 0.002) and 16 months (94.4% vs 54%; p = 0.002). Conclusions: In a single center cohort of JA reflecting real-world practice, JA with DCB had a superior TLR rate up to 16-month follow-up when compared to JA with PTA in treating all comers FP arterial disease.

AB - Background: The long-term outcome of Jetstream atherectomy (JA) with or without adjunctive drug coated balloons (DCB) in a real-world setting remains unknown. We report 16-month target lesion revascularization (TLR) rates on patients treated for femoropopliteal (FP) artery disease with JA in a single center by one operator. Methods: From 1/1/12 to 8/24/16 a total of 311 procedures were performed with atherectomy by a single operator at a single center. Of these procedures, 75 met inclusion and exclusion criteria. This report evaluates the outcomes of these 75 patients treated at index and who were followed up to 16 months. The primary endpoint of the study was clinically driven TLR. Patients were stratified by the use of DCB (vs angioplasty (PTA)) post-JA. TLR was calculated by excluding bailout stenting as TLR. Survival analysis for TLR over time was plotted. Results: 75 patients (49.3% male, mean age 68.0 years, 54.7% diabetes) with de novo or restenotic FP lesions whose symptoms were classified as Rutherford category I-V were enrolled. Adjunctive PTA was performed on 50 patients (26 de novo, 13 in-stent restenosis, 3 non-stent restenosis, 8 mixed lesions) and adjunctive DCB (LUTONIX® 24, IN.PACT® 1) on 25 patients (21 de novo, 1 in-stent restenosis, 2 non-stent restenosis, 1 mixed lesion) (p = 0.0249). There was no difference in the median treated length between the adjunctive PTA (15 cm) and DCB (10 cm) groups (p = 0.0530). The estimated freedom from TLR (fTLR) was significantly higher with atherectomy and adjunctive DCB compared to atherectomy with adjunctive PTA at 12 months (94.7% vs 68.0%, p = 0.002) and 16 months (94.4% vs 54%; p = 0.002). Conclusions: In a single center cohort of JA reflecting real-world practice, JA with DCB had a superior TLR rate up to 16-month follow-up when compared to JA with PTA in treating all comers FP arterial disease.

KW - Atherectomy

KW - De novo lesions

KW - Drug coated balloon

KW - Jetstream

KW - Outcome

KW - Popliteal artery

KW - Restenotic lesions

KW - Superficial femoral artery

UR - http://www.scopus.com/inward/record.url?scp=85042917349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042917349&partnerID=8YFLogxK

U2 - 10.1016/j.carrev.2018.02.003

DO - 10.1016/j.carrev.2018.02.003

M3 - Article

C2 - 30420096

AN - SCOPUS:85042917349

JO - Cardiovascular Revascularization Medicine

JF - Cardiovascular Revascularization Medicine

SN - 1553-8389

ER -